Product Category: Discovery Screening Services
|
At the core of ChanTest’s Discovery Services offering is their major collection of extensively validated ion channel and GPCR cell lines. These, in conjunction with the screening platforms at their disposal and critically their team of experts in ion channel and GPCR drug discovery make ChanTest your ideal partner for outsourced compound screening. Unlike most service organizations, ChanTest has validated its cell lines for testing at each phase of the drug-discovery process. Whether you need initial high-throughput screening of hits, high-sensitivity screens for lead identification and lead optimization, or safety testing in preparation for an Ion Channel Cell lines are available for screening individually or as convenient Channel Panels, organised by ion channel family, organ or therapeutic target. A wide range of GPCRs can be screened with your compounds or using ChanTest’s library of 12,600 compounds. ChanTest delivers Fast, Accurate, Reliable screens throughout the drug discovery process. Hit Identification Hit to Lead Lead Optimisation Safety Testing Contact us to discuss your screening requirements. |
|
|
